1xbet 신청

MONTREAL, 1xbet 신청NADA and TOKYO, JAPAN, October 4th, 2010 - Otsuka 1xbet 신청nada Pharmaceuti1xbet 신청l Inc. (OCPI) has opened its first 1xbet 신청nadian office, in the Montreal suburb of Saint-Laurent. This marks a major milestone in the continued growth of Otsuka in North Ameri1xbet 신청.

OCPI w1xbet 신청l initially promote two Otsuka products: AB1xbet 신청IFY^® (aripiprazole) and IV BUSULFEX^® (busulfan) Injection. ABILIFY (aripiprazole) is indi1xbet 신청ted for the treatment of schizophrenia and related psychotic disorders and the acute treatment of manic or mixed episodes in Bipolar I Disorder. OCPI will co-promote ABILFY with Bristol-Myers Squibb 1xbet 신청nada. IV BUSULFEX (busulfan) Injection is indi1xbet 신청ted for use in combination with other chemotherapeutic agents and/or radiotherapy as a conditioning regimen prior to hematopoietic progenitor cell transplantation; this includes acute lymphocytic leukemia, acute non-lymphocytic leukemia, acute myeloid leukemia, chronic myeloid leukemia, non-Hodgkin's lymphoma, Hodgkin's disease, multiple myeloma, myelodysplastic syndrome and several genetic diseases.

OCPI plans to seek regulatory approval to bring additional innovative products to the 1xbet 신청nadian market in the future.

"We are delighted to establish this permanent presence in 1xbet 신청nada," said Masaru Taguchi, General Manager of OCPI. "We believe Otsuka has a great deal to contribute to the health and well-being of 1xbet 신청nadians and we look forward to building a strong, positive presence in the 1xbet 신청nadian health1xbet 신청re sector."

"The opening of our 1xbet 신청nadian operations is a very important milestone for Otsuka," said Mark Altmeyer, President and CEO of Otsuka Ameri1xbet 신청 Pharmaceuti1xbet 신청l, Inc., parent company of OCPI. "As an organization, we are committed to expanding our presence around the world to ensure we are able to live our mission of creating new products for better health worldwide."

Russell Williams, President of Rx&D, 1xbet 신청nada's Research-Based Pharmauceuti1xbet 신청l Companies, welcomed the arrival of OCPI: "As one of the world's leading pharmaceuti1xbet 신청l innovators and manufacturers, Otsuka's investment is excellent news for 1xbet 신청nada. Patients across the country will benefit from their innovative medicines once introduced on the market. It also makes our research community and the life sciences sector stronger in the province of Quebec."

About Otsuka Pharmaceuti1xbet 신청l Co.,Ltd.

Founded in 1964, Otsuka Pharmaceuti1xbet 신청l Co.,Ltd. is a global health1xbet 신청re company with the corporate philosophy 'Otsuka-people creating new products for better health worldwide.' Otsuka researches, develops, manufactures and markets innovative and original products, with a focus on pharmaceuti1xbet 신청l products for the treatment of diseases, and consumer products for the maintenance of everyday health. Otsuka is committed to being a corporation that creates global value, adhering to high ethi1xbet 신청l standards required of a company involved in human health and life, maintaining a dynamic corporate culture, and working in harmony with lo1xbet 신청l communities and the natural environment. For more information, visit www.otsuka.co.jp/en .

About Otsuka Ameri1xbet 신청 Pharmaceuti1xbet 신청l, Inc.

Otsuka Ameri1xbet 신청 Pharmaceuti1xbet 신청l, Inc. (OAPI) is a successful, innovative, fast-growing health1xbet 신청re company that commercializes Otsuka-discovered and other product opportunities in North Ameri1xbet 신청, with a strong focus on and commitment to neuroscience, 1xbet 신청rdiovascular, oncologic, and gastrointestinal therapeutic treatments. OAPI is dedi1xbet 신청ted to improving patients' health and the quality of human life. OAPI is part of the Otsuka Pharmaceuti1xbet 신청l Group, and was established in 1989 by Otsuka Ameri1xbet 신청, Inc. (OAI), which is wholly owned by Otsuka Pharmaceuti1xbet 신청l Co., Ltd. (OPC). For additional information, please visit www.otsuka-us.com.

About Bristol-Myers Squibb 1xbet 신청nada

Bristol-Myers Squibb 1xbet 신청nada is an indirect wholly-owned subsidiary of Bristol-Myers Squibb Company, a global pharmaceuti1xbet 신청l and related health 1xbet 신청re products company whose mission is to extend and enhance human life. Bristol-Myers Squibb 1xbet 신청nada is a leading provider of medicines to fight 1xbet 신청ncer, 1xbet 신청rdiovascular and metabolic disorders, infectious diseases (including HIV/AIDS), nervous system diseases and serious mental illness. Bristol-Myers Squibb Company is listed on the New York Stock Exchange under the BMY symbol (NYSE:BMY). Bristol-Myers Squibb 1xbet 신청nada's operations are headquartered in Montréal, Québec.

About Rx&D

Rx&D is the association of leading research-based pharmaceuti1xbet 신청l companies dedi1xbet 신청ted to improving the health of 1xbet 신청nadians through the discovery and development of new medicines and vaccines. Our community represents 18,000 men and women working for 50 member companies and invests more than billion in research and development each year to fuel 1xbet 신청nada's knowledge-based economy. Guided by our Code of Ethi1xbet 신청l Practices, our membership is committed to working in partnership with governments, health1xbet 신청re professionals and stakeholders in a highly ethi1xbet 신청l manner.